Equities

Haba Laboratories Inc

4925:TYO

Haba Laboratories Inc

Actions
Consumer DiscretionaryPersonal Goods
  • Price (JPY)1,892.00
  • Today's Change2.00 / 0.11%
  • Shares traded1.10k
  • 1 Year change-19.15%
  • Beta0.8315
Data delayed at least 20 minutes, as of Nov 11 2024 05:49 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HABA LABORATORIES, INC. is principally engaged in the manufacture and sale of cosmetics and dietary supplements. The Company's main business consists of the research, development, manufacture and distribution of women's and men's cosmetics. The Company offers its products by wholesale distribution to department stores and through mail order services to general customers. It also handles wholesale distribution to retailers and wholesalers, as well as the sale of products at its own retail stores.

  • Revenue in JPY (TTM)12.43bn
  • Net income in JPY-1.93bn
  • Incorporated1976
  • Employees631.00
  • Location
    Haba Laboratories Inc1-24-11, Kanda Suda-choCHIYODA-KU 101-0041JapanJPN
  • Phone+81 352966250
  • Fax+81 352966267
  • Websitehttps://haba-lab.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ivresse Co Ltd1.28bn-43.79m1.69bn38.00------1.33-67.12-67.121,951.0917.573.5415.659.9631,936,580.00-12.15---35.48--56.88---3.43--1.00-20.400.9465--24.12--16.12------
Nippon Shikizai, Inc.17.20bn433.82m2.62bn477.006.040.66261.960.1526207.00207.008,207.111,886.560.98284.856.0636,059,350.002.48-0.05553.98-0.079513.3611.122.52-0.07510.65734.550.71--27.975.5461.64-8.33-7.91-4.36
Soiken Holdings Inc5.16bn-662.20m3.40bn90.00--0.5456--0.6592-25.32-25.32197.20238.280.67942.2112.2357,316,200.00-8.735.11-10.026.2648.1246.08-12.854.748.30--0.0027.64-36.16-7.38-246.55---20.16--
C'BON COSMETICS Co Ltd8.42bn-157.17m5.09bn694.00--0.9141--0.6043-36.72-36.721,967.991,300.720.97312.309.1612,138,370.00-1.82-4.32-2.57-5.5475.5076.20-1.87-4.521.52-------0.3103-7.4993.75--15.74-17.81
Premier Antiaging Co Ltd20.36bn-1.48bn6.30bn229.00--1.03--0.3093-170.06-170.062,334.65702.261.762.4410.6988,903,930.00-12.826.12-18.139.9279.0978.28-7.282.351.94--0.28510.00-22.8811.28-102.05--86.76--
Shobido Corp21.27bn602.76m6.44bn232.0010.520.89147.690.302645.6345.631,610.51538.501.376.946.2891,700,140.003.932.106.193.2125.8927.942.871.751.64--0.41552.9518.312.94-7.1137.80-3.8611.20
Adjuvant Holdings Co Ltd4.30bn59.14m6.63bn137.00111.481.5934.151.547.397.39537.79518.850.82171.508.9231,417,440.001.132.251.282.5864.3163.701.372.684.19--0.00141.261.39-2.98-124.74---30.17-12.94
Path Corp2.25bn-184.56m7.30bn46.00--5.48--3.25-3.37-3.3740.8922.091.451.7012.2648,831,020.00-11.92-34.74-15.35-56.3648.7550.26-8.22-22.511.48-28,515.000.00--16.47-8.8131.33--4.73--
HABA LABORATORIES, INC.12.43bn-1.93bn7.44bn631.00--0.8575--0.5986-509.27-509.273,285.812,203.980.95451.0912.5119,691,560.00-14.79-1.97-18.67-2.4567.8870.38-15.50-2.241.835.460.2035--2.38-8.54-199.30---1.730.00
Almado Inc7.23bn325.93m10.98bn55.0032.1211.8931.691.5232.8832.88764.5288.821.771.839.10131,412,400.008.0018.2625.4025.8169.0264.334.519.680.753576.520.760157.9415.4714.7518.7215.82-17.87--
Data as of Nov 11 2024. Currency figures normalised to Haba Laboratories Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

0.92%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 31 Jul 202423.90k0.61%
Daiwa Asset Management Co. Ltd.as of 24 Apr 20249.70k0.25%
Niche Asset Management Ltd.as of 30 Jun 20241.20k0.03%
Dimensional Fund Advisors Ltd.as of 31 Aug 2024897.000.02%
DFA Australia Ltd.as of 31 May 2023299.000.01%
Mitsubishi UFJ Asset Management Co., Ltd.as of 19 Sep 20230.000.00%
Samarang LLPas of 30 Jun 20220.000.00%
More ▼
Data from 30 Jun 2022 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.